ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survival
Authors:
Open Access
- 3 December 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (49)
Abstract
DNA nanotubes can cross blood-brain tumor barrier and enhance survival with no toxicity when used for the local delivery of DOX.Keywords
This publication has 59 references indexed in Scilit:
- Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugatesProceedings of the National Academy of Sciences, 2013
- Scavenger Receptors Mediate Cellular Uptake of Polyvalent Oligonucleotide-Functionalized Gold NanoparticlesBioconjugate Chemistry, 2010
- Affinity of the anthracycline antitumor drugsDoxorubicin and Sabarubicin for human telomeric G-quadruplex structuresPhysical Chemistry Chemical Physics, 2010
- Intracellular Uptake and Trafficking of Difluoroboron Dibenzoylmethane−Polylactide Nanoparticles in HeLa CellsACS Nano, 2010
- Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotidesNucleic Acids Research, 2009
- Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurementsProceedings of the National Academy of Sciences, 2009
- DNA Nanotubes as Combinatorial Vehicles for Cellular DeliveryBiomacromolecules, 2008
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing NanoparticlesBioconjugate Chemistry, 2007
- Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticlesInternational Journal of Cancer, 2004